Selective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.

BACKGROUND In 2005, Ghana adopted artemisinin-based combination therapy (ACT) for primary treatment of falciparum malaria. A comprehensive study of the drug-resistance-associated mutations and their genetic lineages will lead to a better understanding of the evolution of antimalarial drug resistance in this region. METHODS The pfcrt, pfmdr1, dhps, and dhfr mutations associated with chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) resistance and the microsatellite loci flanking these genes were genotyped in Plasmodium falciparum isolates from Ghana. RESULTS The prevalence of mutations associated with both CQ and SP resistance was high in Ghana. However, we observed a decrease in prevalence of the pfcrt K76T mutation in northern Ghana after the change in drug policy from CQ to ACT. Analysis of genetic diversity and differentiation at microsatellite loci flanking all 4 genes indicated that they have been under strong selection, because of CQ and SP use. The triple-mutant pfcrt and dhfr alleles in Ghana were derived from Southeast Asia, whereas the double-mutant dhfr, dhps, and pfmdr1 alleles were of African lineage. CONCLUSION Because of the possible role of pfmdr1 in amodiaquine and mefloquine resistance, demonstrating selection on pfmdr1 and defining lineages of resistant alleles in an African population holds great importance.

[1]  R. Sauerwein,et al.  Concurrence of Plasmodium falciparum dhfr and crt mutations in northern Ghana , 2005, Malaria Journal.

[2]  François Nosten,et al.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number , 2004, The Lancet.

[3]  J. Barnwell,et al.  pfmdr1 Amplification and Fixation of pfcrt Chloroquine Resistance Alleles in Plasmodium falciparum in Venezuela , 2010, Antimicrobial Agents and Chemotherapy.

[4]  N. Duah,et al.  The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs , 2007, Annals of tropical medicine and parasitology.

[5]  P. Rosenthal,et al.  Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso. , 2006, The American journal of tropical medicine and hygiene.

[6]  T. Triglia,et al.  Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Meyer,et al.  The molecular signature of selection underlying human adaptations. , 2006, American journal of physical anthropology.

[8]  P. Newton,et al.  Selection strength and hitchhiking around two anti-malarial resistance genes , 2005, Proceedings of the Royal Society B: Biological Sciences.

[9]  F. Nosten,et al.  Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. , 2006, Molecular biology and evolution.

[10]  O. Gaye,et al.  Defining the origin of Plasmodium falciparum resistant dhfr isolates in Senegal. , 2006, Acta tropica.

[11]  F. Bonhomme,et al.  GENETIX 4.05, logiciel sous Windows TM pour la génétique des populations. , 1996 .

[12]  C. Schlötterer.  Hitchhiking mapping--functional genomics from the population genetics perspective. , 2003, Trends in genetics : TIG.

[13]  Carol Hopkins Sibley,et al.  Characteristics of Plasmodium falciparum dhfr haplotypes that confer pyrimethamine resistance, Kilifi, Kenya, 1987--2006. , 2008, The Journal of infectious diseases.

[14]  F. Mockenhaupt,et al.  Efficacy of chloroquine in the treatment of uncomplicated, Plasmodium falciparum malaria in northern Ghana , 2002, Annals of tropical medicine and parasitology.

[15]  A. Mårtensson,et al.  Short report: Rapid DNA extraction from archive blood spots on filter paper for genotyping of Plasmodium falciparum. , 2005, The American journal of tropical medicine and hygiene.

[16]  B. Weir,et al.  ESTIMATING F‐STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE , 1984, Evolution; international journal of organic evolution.

[17]  A. Ghansah,et al.  Mutations in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance genes, and treatment outcomes in Ghanaian children with uncomplicated malaria. , 2006, Journal of tropical pediatrics.

[18]  J. Barnwell,et al.  Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. , 2006, The Journal of infectious diseases.

[19]  G. Minns,et al.  IN VIVO CHLOROQUINE-RESISTANT FALCIPARUM MALARIA IN WESTERN AFRICA , 1986, The Lancet.

[20]  John C. Wootton,et al.  Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum , 2002, Nature.

[21]  F. Mockenhaupt,et al.  Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. , 2008, The Journal of infectious diseases.

[22]  F. Mockenhaupt,et al.  Large-Scale Surveillance of Plasmodium falciparum crt(K76T) in Northern Ghana , 2007, Antimicrobial Agents and Chemotherapy.

[23]  T. Anderson,et al.  The origins and spread of antimalarial drug resistance: lessons for policy makers. , 2005, Acta tropica.

[24]  Stephen D. E. Park.  Trypanotolerace in West African cattle and the population genetic effects of selection , 2002 .

[25]  A. Kaneko,et al.  Indigenous evolution of Plasmodium falciparum pyrimethamine resistance multiple times in Africa , 2008, The Journal of antimicrobial chemotherapy.

[26]  S. Krudsood,et al.  Independent Evolution of Pyrimethamine Resistance in Plasmodium falciparum Isolates in Melanesia , 2007, Antimicrobial Agents and Chemotherapy.

[27]  F. Mockenhaupt,et al.  Plasmodium falciparum dihydrofolate reductase alleles and pyrimethamine use in pregnant Ghanaian women. , 2001, The American journal of tropical medicine and hygiene.

[28]  J. Wootton,et al.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.

[29]  J. Coppee,et al.  Decreased In Vitro Susceptibility of Plasmodium falciparum Isolates to Artesunate, Mefloquine, Chloroquine, and Quinine in Cambodia from 2001 to 2007 , 2010, Antimicrobial Agents and Chemotherapy.

[30]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[31]  A. M. de Oliveira,et al.  Decline in Sulfadoxine-Pyrimethamine-Resistant Alleles after Change in Drug Policy in the Amazon Region of Peru , 2007, Antimicrobial Agents and Chemotherapy.

[32]  J. Barnwell,et al.  Origin and Evolution of Sulfadoxine Resistant Plasmodium falciparum , 2010, PLoS pathogens.

[33]  F. Mockenhaupt,et al.  Plasmodium falciparum pfcrt and pfmdr1 polymorphisms are associated with the pfdhfr N108 pyrimethamine‐resistance mutation in isolates from Ghana , 2001, Tropical medicine & international health : TM & IH.

[34]  P. Newton,et al.  A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. , 2003, Molecular biology and evolution.

[35]  E. Afari,et al.  Plasmodium falciparum: sensitivity to chloroquine in vivo in three ecological zones in Ghana. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[36]  J. Barnwell,et al.  Multiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in Cambodia. , 2010, The Journal of infectious diseases.

[37]  O. Doumbo,et al.  A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. , 2007, The Journal of infectious diseases.

[38]  J. May,et al.  High Prevalence of Markers for Sulfadoxine and Pyrimethamine Resistance in Plasmodium falciparum in the Absence of Drug Pressure in the Ashanti Region of Ghana , 2005, Antimicrobial Agents and Chemotherapy.

[39]  R. Lewontin,et al.  Distribution of gene frequency as a test of the theory of the selective neutrality of polymorphisms. , 1973, Genetics.

[40]  A. Oduro,et al.  A randomized comparative study of chloroquine, amodiaquine and sulphadoxine–pyrimethamine for the treatment of uncomplicated malaria in Ghana , 2005, Tropical medicine & international health : TM & IH.

[41]  C. Plowe,et al.  Mechanisms of Resistance of Malaria Parasites to Antifolates , 2005, Pharmacological Reviews.

[42]  Georgina S. Humphreys,et al.  Amodiaquine and Artemether-Lumefantrine Select Distinct Alleles of the Plasmodium falciparum mdr1 Gene in Tanzanian Children Treated for Uncomplicated Malaria , 2006, Antimicrobial Agents and Chemotherapy.

[43]  A. Escalante,et al.  Hitchhiking and Selective Sweeps of Plasmodium falciparum Sulfadoxine and Pyrimethamine Resistance Alleles in a Population from Central Africa , 2008, Antimicrobial Agents and Chemotherapy.

[44]  C. Obonyo,et al.  Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y. , 2006, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[45]  Manoj T Duraisingh,et al.  Contribution of the pfmdr1 gene to antimalarial drug-resistance. , 2005, Acta tropica.

[46]  B. Sharp,et al.  Multiple Origins and Regional Dispersal of Resistant dhps in African Plasmodium falciparum Malaria , 2009, PLoS medicine.

[47]  W. Hanage,et al.  eBURST: Inferring Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from Multilocus Sequence Typing Data , 2004, Journal of bacteriology.

[48]  W. Wernsdorfer,et al.  Plasmodium falciparum: susceptibility in vitro and in vivo to chloroquine and sulfadoxine-pyrimethamine in Ghanaian schoolchildren. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[49]  T. Taylor,et al.  Return of chloroquine antimalarial efficacy in Malawi. , 2006, The New England journal of medicine.

[50]  Benjamin Abuaku,et al.  Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana. , 2005, Acta tropica.